Literature DB >> 32422566

MiRNA-106b-5p in human cancers: diverse functions and promising biomarker.

Chaogang Yang1, Rongzhang Dou1, Tailang Yin2, Jinli Ding3.   

Abstract

MicroRNAs (miRNAs), as a class of small, well-conserved, non-coding RNA molecules, hold the capacity to post-transcriptionally suppress the expression of over 50% protein-coding genes. Emerging and accumulating evidence suggests that miRNAs function as the master regulators of multiple pathophysiological processes, and play important roles in diverse human diseases, especially in tumorigenesis and progression. MiR-106b-5p, a member of miR-106b seed family, has been demonstrated to be aberrantly expressed in human solid malignancies, and to play paradoxically opposing functions as an oncomiR or a tumor suppressor in tumor development. In addition, it has been recently reported to be a promising biomarker for prognostic evaluation for cancer patients. In the present review, we provided an overview to summarize the present findings of miR-106b-5p in cancer research fields, thereby establishing comprehensive understanding of its diverse functions and clinical implications in human cancers.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Biomarker; Cancer; MiR-106b-5p; OncomiRNA; Tumor suppressor

Mesh:

Substances:

Year:  2020        PMID: 32422566     DOI: 10.1016/j.biopha.2020.110211

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

Review 1.  miR-106b as an emerging therapeutic target in cancer.

Authors:  Surendra Kumar Sagar
Journal:  Genes Dis       Date:  2021-02-12

2.  Identification of a three-miRNA signature as a novel prognostic model for papillary renal cell carcinoma.

Authors:  Ge Li; Haifan Yang; Yong Cheng; Xin Zhao; Xu Li; Rui Jiang
Journal:  Cancer Cell Int       Date:  2020-07-16       Impact factor: 5.722

Review 3.  MiRNAs and Cancer: Key Link in Diagnosis and Therapy.

Authors:  Yu Shi; Zihao Liu; Qun Lin; Qing Luo; Yinghuan Cen; Juanmei Li; Xiaolin Fang; Chang Gong
Journal:  Genes (Basel)       Date:  2021-08-23       Impact factor: 4.096

4.  Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA-mRNA Network in Neuroblastoma Via Bioinformatics Analysis.

Authors:  Bo Chen; Zhongyan Hua; Xiuni Qin; Zhijie Li
Journal:  Neurochem Res       Date:  2020-10-26       Impact factor: 3.996

5.  Secondary Structural Model of MALAT1 Becomes Unstructured in Chronic Myeloid Leukemia and Undergoes Structural Rearrangement in Cervical Cancer.

Authors:  Matthew C Wang; Phillip J McCown; Grace E Schiefelbein; Jessica A Brown
Journal:  Noncoding RNA       Date:  2021-01-13

6.  Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy.

Authors:  Stefanos Kachris; Chara Papadaki; Konstantinos Rounis; Eliza Tsitoura; Chrysanthi Kokkinaki; Christoforos Nikolaou; George Sourvinos; Dimitrios Mavroudis
Journal:  Cancer Manag Res       Date:  2021-11-02       Impact factor: 3.989

7.  Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing.

Authors:  Md Parvez Mosharaf; Md Kaderi Kibria; Md Bayazid Hossen; Md Ariful Islam; Md Selim Reza; Rashidul Alam Mahumud; Khorshed Alam; Jeff Gow; Md Nurul Haque Mollah
Journal:  Vaccines (Basel)       Date:  2022-08-03

8.  MicroRNA-802 Suppresses Tumorigenesis of Colorectal Cancer via Regulating UBN2.

Authors:  Tao Yang; Qiuying Guo; Dongsheng Li; Guang Bai; Hongzhi Sun; Wei Wang
Journal:  Cancer Manag Res       Date:  2020-11-04       Impact factor: 3.989

9.  Long non-coding RNA H19 protects against intracerebral hemorrhage injuries via regulating microRNA-106b-5p/acyl-CoA synthetase long chain family member 4 axis.

Authors:  Bing Chen; Haoran Wang; Chenglin Lv; Chongdan Mao; Yuguang Cui
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.